Last reviewed · How we verify

NCT04630704

Evaluating A Non-Invasive Tissue Perfusion Monitor

Status unknown Last updated 16 November 2020
What this trial tests

trial testing Pedra in Circulatory; Change in 50 participants. Status unknown.

Timeline
7 December 2020
Primary endpoint
1 April 2021
1 July 2021

Quick facts

Lead sponsorPedra Technology, PTE LTD
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment50
Start date7 December 2020
Primary completion1 April 2021
Estimated completion1 July 2021

Drugs / interventions tested

Conditions studied

Sponsor

Pedra Technology, PTE LTD

Who can join

Adults 40 to 90, any sex, with Circulatory; Change. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Pedra perfusion system will be used to assess changes in perfusion in response to physiological stimuli. It will be compared to other standard diagnostics.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Pedra Technology, PTE LTD trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04630704.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing